Key Highlights

● SNPS closed at $509.99 on 9 October 2026.

● Market data consensus target is $570.04 from 26 analysts.

● Targets range from $475 to $640.

● Deutsche Bank reiterated a Buy rating and raised its target from $590 to $640.

Synopsys (NASDAQ:SNPS), a constituent of both the S&P 500 and the Nasdaq-100, ended Friday 9 October 2026 at $509.99. The consensus target sits moderately above the share price.

What Is the Latest Analyst Price Target?

Market data reports a consensus 12-month target of $570.04 from 26 analysts with ratings in the past 12 months. The highest target is $640, attributed to Deutsche Bank, and the lowest is $475, attributed to BNP Paribas Exane. The second data set reports a mean of $570.57, a median of $580, a high of $700 and a low of $414.77 across 25 analysts. The averages from the two data sets are almost identical, but the extremes differ, which is typical when data sets use different samples and update at different times. The market data consensus is consistent with the named targets published since late August, which mostly sit between $475 and $640.

What Are Wall Street Analysts Saying?

Sentiment is clearly positive. Market data records 22 Buy ratings (including one Strong Buy), four Hold ratings and no Sell ratings. The second data set shows 23 Buy or Strong Buy ratings, two Holds and no Sells.

A wave of target increases came on 1 October. Deutsche Bank reiterated a Buy rating and raised its target from $590 to $640. Bank of America raised its target from $500 to $600, Rosenblatt from $575 to $620 with a Buy rating, KeyCorp from $600 to $605 with an Overweight rating, and Wells Fargo from $475 to $540 with an Overweight rating. BNP Paribas Exane lifted its target from $420 to $475 with a Neutral rating. On 25 September, market data lists Roth Capital upgrading to Buy, and Bernstein and Barclays initiating coverage with Outperform and Overweight ratings respectively.

HSBC is listed as downgrading from Buy to Reduce on the same date. Earlier, in late August, JPMorgan lowered its target from $650 to $600 and Mizuho lowered from $600 to $550, while UBS set a $570 target. Morgan Stanley lowered its target from $525 to $500 on 19 August with an Equal Weight rating.

What Could Help the Stock Reach the Price Target?

Market data reports that Synopsys announced second-quarter results on 26 August 2026, with earnings per share of $3.91 and revenue of $2.48 billion, which market data says exceeded consensus. Market data also lists fourth-quarter 2026 earnings per share guidance of $4.10 to $4.16. If the company delivers within or above that range, and the recent flurry of target increases proves to be the start of a longer trend, the shares could move towards the consensus level.

What Could Prevent the Stock Reaching the Target?

The target range is wide, from $475 to $640 on market data and from about $415 to $700 on the second data set, which shows that analysts disagree about how the company will perform.

Synopsys Versus Its Analyst Targets

Synopsys closed at $509.99 on 9 October 2026, against a market data consensus target of $570.04. Deutsche Bank reiterated a Buy rating and raised its target from $590 to $640.